Previous close | 59.50 |
Open | 59.50 |
Bid | 62.90 |
Ask | 71.50 |
Strike | 755.00 |
Expiry date | 2023-04-21 |
Day's range | 59.50 - 59.50 |
Contract range | N/A |
Volume | |
Open interest | 111 |
Pipelines updates from Viking Therapeutics (VKTX) and Intra-Cellular (ITCI) are the key highlights for the biotech sector.
Regeneron Pharmaceuticals (REGN) has been a bright spot in the market lately.
Unity's (UBX) phase II ENVISION study on UBX1325 fails to meet the non-inferiority threshold compared to aflibercept through 24 weeks in the wet AMD study.